Skip to main content
Erschienen in: Journal of Behavioral Medicine 6/2018

17.05.2018

Methamphetamine-associated dysregulation of the hypothalamic–pituitary–thyroid axis

verfasst von: Deborah L. Jones, Adam W. Carrico, Suat Babayigit, Violeta J. Rodriguez, Carlos Aguila, Mahendra Kumar

Erschienen in: Journal of Behavioral Medicine | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

Methamphetamine and HIV impair thyroid function, but few studies have investigated their combined effects on thyroid dysregulation. This study examined the associations of methamphetamine use alone and in combination with HIV on thyroid function among men in South Florida. Measures of thyroid function in methamphetamine-using, HIV-infected (METH+HIV+; n = 127) and HIV-negative (METH+HIV−; n = 46) men who have sex with men (MSM) were compared to non-methamphetamine-using, HIV-negative men (METH−HIV−; n = 136). Thyroid function was dysregulated in methamphetamine-using MSM, irrespective of HIV status. Both meth-using groups had greater odds of abnormal thyroid stimulating hormone levels and significantly higher mean free triiodothyronine (T3) levels. Elevated free T3 was associated with greater depressive symptoms. Overall, outcomes have important implications for assessment of thyroid function in methamphetamine users, particularly among those presenting with depression.
Literatur
Zurück zum Zitat Carrico, A. W., Rodriguez, V. J., Jones, D. L., & Kumar, M. K. (2017). Short circuit: Disaggregation of adrenocorticotropic hormone and cortisol levels in HIV-positive, methamphetamine-using men who have sex with men. Human Psychopharmacology Clinical and Experimental. https://doi.org/10.1002/hup.2645 CrossRefPubMed Carrico, A. W., Rodriguez, V. J., Jones, D. L., & Kumar, M. K. (2017). Short circuit: Disaggregation of adrenocorticotropic hormone and cortisol levels in HIV-positive, methamphetamine-using men who have sex with men. Human Psychopharmacology Clinical and Experimental. https://​doi.​org/​10.​1002/​hup.​2645 CrossRefPubMed
Zurück zum Zitat Ellis, R. J., Childers, M. E., Cherner, M., Lazzaretto, D., Letendre, S., Grant, I., et al. (2003). Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. Journal of Infectious Diseases, 188, 1820–1826. https://doi.org/10.1086/379894 CrossRefPubMed Ellis, R. J., Childers, M. E., Cherner, M., Lazzaretto, D., Letendre, S., Grant, I., et al. (2003). Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. Journal of Infectious Diseases, 188, 1820–1826. https://​doi.​org/​10.​1086/​379894 CrossRefPubMed
Zurück zum Zitat Finlayson, T. J., Le, B., Smith, A., Bowles, K., Cribbin, M., Miles, I., et al. (2011). HIV risk, prevention, and testing behaviors among men who have sex with men–National HIV Behavioral Surveillance System, 21 US cities, United States, 2008. MMWR Surveill Summ, 60, 1–34.PubMed Finlayson, T. J., Le, B., Smith, A., Bowles, K., Cribbin, M., Miles, I., et al. (2011). HIV risk, prevention, and testing behaviors among men who have sex with men–National HIV Behavioral Surveillance System, 21 US cities, United States, 2008. MMWR Surveill Summ, 60, 1–34.PubMed
Zurück zum Zitat First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (2002). Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition With Psychotic Screen (SCID-I/P W/ PSY SCREEN). New York: Biometrics Research, New York State Psychiatric Institute. First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (2002). Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition With Psychotic Screen (SCID-I/P W/ PSY SCREEN). New York: Biometrics Research, New York State Psychiatric Institute.
Zurück zum Zitat Gozashti, M. H., Mohammadzadeh, E., Divsalar, K., & Shokoohi, M. (2014). The effect of opium addiction on thyroid function tests. Journal of Diabetes and Metabolic Disorders, 13, 5.CrossRef Gozashti, M. H., Mohammadzadeh, E., Divsalar, K., & Shokoohi, M. (2014). The effect of opium addiction on thyroid function tests. Journal of Diabetes and Metabolic Disorders, 13, 5.CrossRef
Zurück zum Zitat Hage, M. P., & Azar, S. T. (2012). The link between thyroid function and depression. Journal of Thyroid Research, 2012, 1–8.CrossRef Hage, M. P., & Azar, S. T. (2012). The link between thyroid function and depression. Journal of Thyroid Research, 2012, 1–8.CrossRef
Zurück zum Zitat Li, S., Yan, S. Y., Bao, Y., Lian, Z., Qu, Z., Wu, Y. C., et al. (2013). Depression and alterations in hypothalamic–pituitary–adrenal and hypothalamic–pituitary–thyroid axis function in male abstinent methamphetamine abusers. Human Psychopharmacology: Clinical and Experimental, 28, 477–483.CrossRef Li, S., Yan, S. Y., Bao, Y., Lian, Z., Qu, Z., Wu, Y. C., et al. (2013). Depression and alterations in hypothalamic–pituitary–adrenal and hypothalamic–pituitary–thyroid axis function in male abstinent methamphetamine abusers. Human Psychopharmacology: Clinical and Experimental, 28, 477–483.CrossRef
Zurück zum Zitat Passaro, R. C., Pandhare, J., Qian, H. Z., & Dash, C. (2015). the complex interaction between methamphetamine abuse and HIV-1 pathogenesis. Journal of Neuroimmune Pharmacology, 10, 477–486.CrossRef Passaro, R. C., Pandhare, J., Qian, H. Z., & Dash, C. (2015). the complex interaction between methamphetamine abuse and HIV-1 pathogenesis. Journal of Neuroimmune Pharmacology, 10, 477–486.CrossRef
Zurück zum Zitat Pingitore, A., Landi, P., Taddei, M. C., Ripoli, A., L’Abbate, A., & Iervasi, G. (2005). Triiodothyronine levels for risk stratification of patients with chronic heart failure. American Journal of Medicine, 118, 132–136.CrossRef Pingitore, A., Landi, P., Taddei, M. C., Ripoli, A., L’Abbate, A., & Iervasi, G. (2005). Triiodothyronine levels for risk stratification of patients with chronic heart failure. American Journal of Medicine, 118, 132–136.CrossRef
Zurück zum Zitat Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385–401.CrossRef Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385–401.CrossRef
Zurück zum Zitat Zuloaga, D. G., Jacobskind, J. S., & Raber, J. (2015). Methamphetamine and the hypothalamic-pituitary-adrenal axis. Frontiers in Neuroscience, 9, 178.PubMedPubMedCentral Zuloaga, D. G., Jacobskind, J. S., & Raber, J. (2015). Methamphetamine and the hypothalamic-pituitary-adrenal axis. Frontiers in Neuroscience, 9, 178.PubMedPubMedCentral
Zurück zum Zitat Zuloaga, D. G., Siegel, J. A., Acevedo, S. F., Agam, M., & Raber, J. (2013). Developmental methamphetamine exposure results in short- and long-term alterations in hypothalamic-pituitary-adrenal-axis-associated proteins. Developmental Neuroscience, 35, 338–346. https://doi.org/10.1159/000351278 CrossRefPubMed Zuloaga, D. G., Siegel, J. A., Acevedo, S. F., Agam, M., & Raber, J. (2013). Developmental methamphetamine exposure results in short- and long-term alterations in hypothalamic-pituitary-adrenal-axis-associated proteins. Developmental Neuroscience, 35, 338–346. https://​doi.​org/​10.​1159/​000351278 CrossRefPubMed
Metadaten
Titel
Methamphetamine-associated dysregulation of the hypothalamic–pituitary–thyroid axis
verfasst von
Deborah L. Jones
Adam W. Carrico
Suat Babayigit
Violeta J. Rodriguez
Carlos Aguila
Mahendra Kumar
Publikationsdatum
17.05.2018
Verlag
Springer US
Erschienen in
Journal of Behavioral Medicine / Ausgabe 6/2018
Print ISSN: 0160-7715
Elektronische ISSN: 1573-3521
DOI
https://doi.org/10.1007/s10865-018-9935-6

Weitere Artikel der Ausgabe 6/2018

Journal of Behavioral Medicine 6/2018 Zur Ausgabe

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.